Özlem Sönmez

431 total citations
42 papers, 288 citations indexed

About

Özlem Sönmez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Özlem Sönmez has authored 42 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Özlem Sönmez's work include Cancer Immunotherapy and Biomarkers (6 papers), COVID-19 and healthcare impacts (4 papers) and Cancer Diagnosis and Treatment (4 papers). Özlem Sönmez is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), COVID-19 and healthcare impacts (4 papers) and Cancer Diagnosis and Treatment (4 papers). Özlem Sönmez collaborates with scholars based in Türkiye, United States and Cambodia. Özlem Sönmez's co-authors include Olcay Yeğin, Nihal Oygür, Ünal Erkorkmaz, Fatih Altıntoprak, Serbülent Gökhan Beyaz, Tolga Ergönenç, Başak Oyan, Ülkü Yalçıntaş Arslan, Berna Öksüzoğlu and Mehmet Akif Öztürk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Medicine.

In The Last Decade

Özlem Sönmez

39 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özlem Sönmez Türkiye 9 105 98 68 40 37 42 288
Katie Wang Canada 8 118 1.1× 54 0.6× 35 0.5× 55 1.4× 63 1.7× 11 356
Bart Frizzell United States 11 104 1.0× 200 2.0× 40 0.6× 76 1.9× 39 1.1× 41 402
Hedieh K. Eslamy United States 9 54 0.5× 136 1.4× 27 0.4× 111 2.8× 19 0.5× 13 398
M. Cremonesi Italy 10 85 0.8× 46 0.5× 12 0.2× 40 1.0× 39 1.1× 19 344
Chiara Monagheddu Italy 8 112 1.1× 95 1.0× 36 0.5× 57 1.4× 13 0.4× 11 405
Chandra Sekhar Bal India 12 85 0.8× 136 1.4× 65 1.0× 62 1.6× 18 0.5× 23 330
Anna Martín Spain 6 96 0.9× 23 0.2× 45 0.7× 55 1.4× 11 0.3× 11 515
Michael Scott United States 8 63 0.6× 70 0.7× 45 0.7× 118 3.0× 6 0.2× 22 332
Christian Jehn Germany 9 124 1.2× 56 0.6× 20 0.3× 34 0.8× 19 0.5× 16 320
Paola Fidani Italy 13 73 0.7× 119 1.2× 36 0.5× 47 1.2× 23 0.6× 23 472

Countries citing papers authored by Özlem Sönmez

Since Specialization
Citations

This map shows the geographic impact of Özlem Sönmez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Sönmez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Sönmez more than expected).

Fields of papers citing papers by Özlem Sönmez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Sönmez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Sönmez. The network helps show where Özlem Sönmez may publish in the future.

Co-authorship network of co-authors of Özlem Sönmez

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Sönmez. A scholar is included among the top collaborators of Özlem Sönmez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Sönmez. Özlem Sönmez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Arıbal, Erkin, et al.. (2022). Validation of bioelectrical impedance analysis in the evaluation of body composition in patients with breast cancer. Nutrition in Clinical Practice. 38(4). 817–829. 6 indexed citations
4.
Sönmez, Özlem, et al.. (2022). Palbociclib Associated Deep Vein Thrombosis: A Case Report. Acta Oncologica Turcica. 55(1). 68–71. 1 indexed citations
5.
Sönmez, Özlem, et al.. (2021). In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast Cancer Cells. Cancers. 13(21). 5322–5322. 4 indexed citations
7.
Çınkır, Havva Yeşil, Fatih Yıldiz, Ülkü Yalçıntaş Arslan, et al.. (2020). Primary Anorectal Malignant Melanoma: A Single Center Experience. Acta Oncologica Turcica. 53(1). 68–73. 1 indexed citations
8.
Üyetürk, Ümmügül, Kaan Helvacı, Özlem Sönmez, et al.. (2016). Clinical outcomes and prognostic factors of adult’s Ewing sarcoma family of tumors: single center experience. Współczesna Onkologia. 2(2). 141–146. 8 indexed citations
9.
Beyaz, Serbülent Gökhan, et al.. (2015). Postmastectomy Pain. Chinese Medical Journal. 129(1). 66–71. 47 indexed citations
10.
Sönmez, Özlem, Ertuğrul Güçlü, Ümmügül Üyetürk, et al.. (2015). Which One is More Effective, Filgrastim or Lenograstim, During Febrile Neutropenia Attack in Hospitalized Patients with Solid Tumors?. Asian Pacific Journal of Cancer Prevention. 16(3). 1185–1189. 1 indexed citations
11.
Bal, Öznur, Ülkü Yalçıntaş Arslan, Ayşe Durnalı, et al.. (2015). Progesterone receptor status in determining the prognosis of estrogen receptor positive/ HER2 negative breast carcinoma patients.. PubMed. 20(1). 28–34. 7 indexed citations
12.
13.
Sönmez, Özlem, Ülkü Yalçıntaş Arslan, Kaan Helvacı, et al.. (2014). Effects of comorbidities and functional living activities on survival in geriatric breast cancer patients. Współczesna Onkologia. 3(3). 204–210. 8 indexed citations
14.
Üyetürk, Ümmügül, Berna Öksüzoğlu, İbrahim Türker, et al.. (2014). Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology. Medical Oncology. 31(4). 929–929. 5 indexed citations
15.
Türker, İbrahim, Ülkü Yalçıntaş Arslan, Ozan Yazıcı, et al.. (2014). Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients. Breast Care. 9(6). 421–427. 5 indexed citations
16.
Öztürk, Mehmet Akif, et al.. (2014). Should we be more cautious about replacement of vitamin B12 in patients with cancer receiving cytotoxic chemotherapy?. Medical Hypotheses. 83(6). 726–729. 1 indexed citations
17.
Türker, İbrahim, Ümmügül Üyetürk, Özlem Sönmez, et al.. (2013). Detection of Circulating Tumor Cells in Breast Cancer Patients: Prognostic Predictive Role. Asian Pacific Journal of Cancer Prevention. 14(3). 1601–1607. 9 indexed citations
18.
Seber, S., Mehmet Küçüköner, Özlem Sönmez, et al.. (2013). Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 14(9). 5185–5188. 8 indexed citations
19.
Demırcı, Umut, Bilge Aktaş, Ahmet Alacacıoğlu, et al.. (2013). Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO). Journal of Cancer Research and Clinical Oncology. 139(5). 829–835. 7 indexed citations
20.
Berk, Velı, Nuriye Özdemir, Metin Özkan, et al.. (2012). XELOX versus FOLFOX4 as Second Line Chemotherapy in Advanced Pancreatic Cancer. Hepatogastroenterology. 59(120). 2635–9. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026